Responses
Regular and young investigator award abstracts
Cellular therapies
117 Rapid point-of-care subcutaneous CAR-T from blood draw to injection in 4 hours with modified LV encoding CARs and synthetic driver elements enables efficient CAR-T expansion and tumor regression
Compose a Response to This Article
Other responses
No responses have been published for this article.
